logarithmic but biphasic in nature. The biological half-life of the drug was shorter 124 h if estimated by visual inspection; 13 h if estimated by the method of residuals (1)1 during the first two days, longer (52 h) for the following three days (Figure 1 ). At therapeutic concentration in plasma, digoxin enters the elimination (/3) phase from the distribution (a) phase within 7 to 12 h after an oral dose (2) ; the mean half-life for digoxin elimination is about 1.6 days (39 h) in individuals whose renal and hepatic function is normal (3) . Dungan et al. (4) reported that the half-life of digoxin in children is similar to that found in adults with normal renal function (4).
We found four cases (Table 1) 
To the Editor:
The buffers most commonly used in RIA systems for the measurement of thyroid hormones in human serum are Tris (1, 2) , phosphate-buffered saline (PBS) (1,2), and barbital (3). Thimerosal (Merthiolate), salicylate, and 8-anilino-1-naphthlene sulfonic acid (ANS) are frequently used to block the effects of thyroxin-binding globulin
(1-.3).
Commercially available RIA kits usually contain ready-to-use tracer solutions prepared with these buffers. Because exposure to light is suspected to be responsible for erroneous assay results, we investigated the influence of light on the performance of lml.labeled triiodothyronine (1ssIT3) in these different buffer systems.
Using the Chloramine T method (4, 5), we prepared '251-T3 with a specific activity of 3000 CiJg (#{176} 72.15 TBq/ nmol). The tracer solutions contained about 60 000 cpmlmL, in the following buffer systems: (a) barbital (80 mmol/ L, pH 8.6) and sodium salicylate (30 mmollL); (b) Tris, (50 mmolIL, pH 8.9) and thimerosal (7 mmol/L);
and (c) phosphate (100 mmol/L, pH 7.6), sodium chloride(150mmol/L) and ANS (6 mmollL). The last is abbreviated PBS/ ANS. We placed 100 mL of each solution in clear glass bottles, irradiated with ultraviolet light (254 nm; CA-MAG, West Berlin, F.R.G.) at a distance of 5 cm for up to 66 h, and tested the irradiated solutions for use in a commercially available coated-tube RIA system (SPAC T3; Byk-Mallinckrodt, Dietzenbach, F.R.G.). Figure 1 shows that zero binding decreases with increasing duration of ultraviolet irradiation, an effect most pronounced in the Tris buffer system, where binding decreases by 5% after only 1 h of irradiation and by more than 25% after 24 h. With the barbital buffer system the decrease is smaller (4% after 2 h, 15% after 66 h of ultraviolet light). In the PBS/ANS system, zero binding of 125I-T3remains virtually constant. Similar observations were made in the discrimination difference (D) of the standard curve, i.e., zero binding minus the binding of the standard containing the highest concentration of T3. The PBS/ANS system showed no change in discrimination, but the barbital system had a decrease of 13%. We made no further measure- The control values were in the expected range in the PBS/ANS system and also-in spite of the deterioration in zero binding and discrimination-in the barbital buffer system, over the whole range of irradiation.
Results were similar when we incubated the assay mixture for 2 h in bright sunlight: the Tris buffersystem yielded erroneous results but the other systems performed well. After five weeks of storage of the tracers in the cold room, zero binding of '25I-T3 in the Iris buffer system decreased by 10% if exposed to light but remained constant if the tracer was protected from light. Using chromatographic methods, we detected no sizable amount of 1251 or any other radioactive compound except '251-T3 in he irradiated samples. The cause for the deterioration of zero binding, discrimination, and consequently of assay results, especially in the Tris buffer system, remains to be clarified.
We conclude that the use of '25I-T in PBS/ANS is not sensitive to light. 'I-T3 in barbital/sodium salicylate is somewhat sensitive to light, but assay results are still acceptable. 1251-T3in Tris/thimerosal is very sensitive to light, and ultraviolet or bright sunlight should be excluded during the assay procedure.
